本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Veru Inc.

2.50
+0.01000.40%
盤後2.500.00000.00%19:56 EST
成交量:5.00萬
成交額:12.35萬
市值:4,012.60萬
市盈率:-2.10
高:2.55
開:2.49
低:2.40
收:2.49
52周最高:7.40
52周最低:2.10
股本:1,605.04萬
流通股本:1,448.04萬
量比:0.72
換手率:0.35%
股息:- -
股息率:- -
每股收益(TTM):-1.1898
每股收益(LYR):-1.5517
淨資產收益率:-60.25%
總資產收益率:-42.92%
市淨率:1.08
市盈率(LYR):-1.61

資料載入中...

公司資料

公司名字:
Veru Inc.
交易所:
NASDAQ
成立時間:
1971
員工人數:
20
公司地址:
2916 North Miami Avenue,Suite 1000,Miami,Florida,United States
郵編:
33127
電話:
傳真:
- -
簡介:
Veru Inc.於1971年在威斯康星州成立。公司是一家臨床後期生物製藥公司,專註於研發治療心臟代謝和炎症性疾病的新藥。該公司的藥物開發計劃包括兩個晚期新化學實體,enobosarm和sabizabulin。

董事

名稱
職位
Harry Fisch
Chief Corporate Officer and Director and Vice Chairman
Mitchell S. Steiner
Chairman of the Board and Chief Executive Officer and Director and President
Grace Hyun
Director
Loren Katzovitz
Director
Lucy Lu
Director
Michael L. Rankowitz
Director

股東

名稱
職位
Mitchell S. Steiner
Chairman of the Board and Chief Executive Officer and Director and President
Michele Greco
Chief Administrative Officer and Chief Financial Officer
Harry Fisch
Chief Corporate Officer and Director and Vice Chairman
K. Gary Barnette
Chief Scientific Officer